KriSan Biotech is a Taiwan company and was founded in August, 2015.  KriSan Biotech has a group of professional team with 15+ years API experiences and provides world-class services to support process and analytical method R&D and validation, CGMP production, CMC compiling and regulatory consultation. 

KriSan Biotech offers high technical barriers APIs of small molecule, peptide, peptide-drug conjugate (PDC), oligonucleotide, and complex drug substances to pharmaceutical industries worldwide for both Generic and Contract Development and Manufacturing (CDMO) market.

KriSan Biotech has more than 45 customers, and the region includes USA, Japan, European, Singapore, Middle East and Taiwan.  There are 88 products delivered as of 2021.12.31.  Among then, 64 products are small molecule, 14 products are complex drug substance, 8 products are peptide, and 2 products are oligonucleotide.